Potential Target for Severe Asthma, Other Chronic Inflammatory Diseases Identified – Lung Disease News


Lung Disease News

Potential Target for Severe Asthma, Other Chronic Inflammatory Diseases Identified
Lung Disease News
From previous research it was known that Dkk-1, a protein produced by platelets (blood cells responsible for clotting), inhibits tissue repair, a feature that is common in chronic inflammatory disorders such as asthma, autoimmune diseases and cancer

View full post on asthma – Google News

Syndecan-4 identified as novel target for asthma treatment [PreClinical] – 2 Minute Medicine


2 Minute Medicine

Syndecan-4 identified as novel target for asthma treatment [PreClinical]
2 Minute Medicine
Study Rundown: Asthma, an immune system disorder characterized by airway inflammation and difficulty breathing, affects about 25 million people in the United States alone. Both long- and short-term medications are available for regulating inflammation

View full post on asthma – Google News

New target identified that can lead to potential therapies for Asthma – ANINEWS


ANINEWS

New target identified that can lead to potential therapies for Asthma
ANINEWS
Specifically, the scientists demonstrated that T helper 2 (Th2) type inflammations in allergic asthma involves dendritic cells (DC), a type of white blood cell, which trigger a reduction in the production of cyclic AMP or cAMP, a key messenger molecule

and more »

View full post on asthma – Google News